Zomedica (ZOM) said Monday that it has launched two new canine assays for its Truforma in-clinic biosensor testing platform.

One of the tests detects NT-proBNP in dogs, an indication of conditions such as congestive heart failure, the company said.

Another is used to detect progesterone levels, which can be used to determine optimal breeding dates, timing cesarean sections, and detecting reproductive disorders, the company said.

The test delivery results are available in less than 20 minutes, the company said,